oid_32ecc0b4-c81a-e311-b25bb499bafdbf28_Prokarium - Main Logo - for white background.jpg

Prokarium Ltd

R&D/Manufacturing

  • Funding stage: Series B
  • Technology type: Platform Technology
  • North London
Membership category
Corporate

London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH, United Kingdom

Prokarium Ltd at a glance

Prokarium is a clinical-stage UK biotech company combining cutting-edge synthetic biology tools with AI-enabled discovery to create next generation bacterial immunotherapies to treat cancer.

About Prokarium Ltd

Prokarium is a clinical-stage biotech company based in the UK. We combine cutting edge synthetic biology tools with AI-enabled discovery to create next generation bacterial immunotherapies to treat a wide range of solid cancers. Our lead program, currently advancing in US clinical trials for non-muscle invasive bladder cancer (NMIBC), aims to transform the treatment paradigm by providing a superior, more effective therapy for patients. In addition, our Living Cures platform allows the creation of off-the-shelf, programmable therapeutics to enable the targeted delivery of therapeutic payloads directly at the site of the tumour. 

Therapeutic area(s)

Articles Prokarium Ltd has contributed to